Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar wodeqian (77.47) Submitted: 11/2/2010 10:39:40 AM : Outperform Start Price: $12.63 ALNY Score: -28.79

M* 5 Star Pick

Report this Post 1 Comment
Member Avatar wodeqian (77.47) Submitted: 4/4/2012 4:45:26 PM
Recs: 0

No any more...

Featured Broker Partners


Advertisement